Previous data indicate that the injection of dopaminergic drugs induces changes in cerebellar 3′,5′‐guanosine monophosphate (cGMP) content. Accordingly, we have investigated the effects of haloperidol, sulpiride, or apomorphine on cerebellar prostaglandin (PG) concentration, a parameter related to cGMP content. Results obtained show that dopamine receptor blocking agents, such as haloperidol and sulpiride, significantly decrease cerebellar PGE2 and PGF2α concentrations, while opposite changes are induced by apomorphine, a dopamine receptor agonist
Effects of dopaminergic drugs on cerebellar prostaglandin concentrations
GRASSO, Alfio Antonio;PATTI, Francesco;CONDORELLI, Daniele Filippo;RAMPELLO, Liborio;
1983-01-01
Abstract
Previous data indicate that the injection of dopaminergic drugs induces changes in cerebellar 3′,5′‐guanosine monophosphate (cGMP) content. Accordingly, we have investigated the effects of haloperidol, sulpiride, or apomorphine on cerebellar prostaglandin (PG) concentration, a parameter related to cGMP content. Results obtained show that dopamine receptor blocking agents, such as haloperidol and sulpiride, significantly decrease cerebellar PGE2 and PGF2α concentrations, while opposite changes are induced by apomorphine, a dopamine receptor agonistFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
J. Neurochem. 1983-prostaglandin.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
140.83 kB
Formato
Unknown
|
140.83 kB | Unknown | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
